Cagas, Eugenio B.

HRN: 11-61-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/21/2026
06/28/2026
IV
900mg
Q8
Soft Tissue Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines